Naftifine hydrochloride/Ketoconazole

萘替芬酮康唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNaftifine hydrochloride/Ketoconazole
Drug Alias Name酮康唑/盐酸萘替芬Ketoconazole+Naftifine hydrochloride盐酸萘替芬+酮康唑Ketoconazole/Naftifine hydrochloride酮康唑+盐酸萘替芬 +[9] 
ClassificationSmall molecules
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsErgosterol biosynthesis inhibitors
TargetsErgosterolLanosterol 14α-demethylase
Therapy Area/IndicationsMycoses
Global Approved IndicationsMycoses
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryMainland China
Original Approved Date2005/09/26
Country/TerritoryMainland China
CombinationsYes Naftifine hydrochlorideKetoconazole
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChongqing Huapont Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Huapont Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMycoses
Inactive IndicationsN/A

Other Information

ATC CodeD01A
Related LinksN/A